tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (HK:1093)
:1093
Hong Kong Market

CSPC Pharmaceutical Group (1093) Financial Statements

Compare
24 Followers

CSPC Pharmaceutical Group Financial Overview

CSPC Pharmaceutical Group's market cap is currently HK$105.60B. The company's EPS TTM is HK$0.0893777856; its P/E ratio is 25.41; and it has a dividend yield of 2.70%. CSPC Pharmaceutical Group is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is HK$0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueHK$ 29.54BHK$ 31.47BHK$ 31.59BHK$ 27.41BHK$ 23.58B
Gross ProfitHK$ 20.67BHK$ 22.19BHK$ 22.73BHK$ 20.79BHK$ 17.67B
Operating IncomeHK$ 5.45BHK$ 7.01BHK$ 6.93BHK$ 6.14BHK$ 5.14B
EBITDAHK$ 7.18BHK$ 8.59BHK$ 8.85BHK$ 7.57BHK$ 6.80B
Net IncomeHK$ 4.41BHK$ 5.88BHK$ 6.22BHK$ 5.51BHK$ 4.88B
Balance Sheet
Cash & Short-Term InvestmentsHK$ 8.25BHK$ 13.09BHK$ 13.87BHK$ 13.87BHK$ 10.47B
Total AssetsHK$ 47.23BHK$ 50.92BHK$ 41.77BHK$ 42.50BHK$ 35.65B
Total DebtHK$ 507.33MHK$ 706.90MHK$ 659.28MHK$ 115.04MHK$ 523.95M
Net DebtHK$ -6.27BHK$ -11.31BHK$ -11.00BHK$ -11.24BHK$ -8.13B
Total LiabilitiesHK$ 11.20BHK$ 11.26BHK$ 11.07BHK$ 9.37BHK$ 7.96B
Stockholders' EquityHK$ 34.33BHK$ 36.53BHK$ 29.77BHK$ 31.79BHK$ 26.48B
Cash Flow
Free Cash FlowHK$ 1.86BHK$ 2.29BHK$ 6.62BHK$ 4.15BHK$ 5.91B
Operating Cash FlowHK$ 4.53BHK$ 4.18BHK$ 9.23BHK$ 5.86BHK$ 7.67B
Investing Cash FlowHK$ -3.86BHK$ 607.27MHK$ -6.80BHK$ -637.33MHK$ -2.60B
Financing Cash FlowHK$ -5.25BHK$ -2.30BHK$ -1.90BHK$ -2.20BHK$ -1.65B
Currency in HKD

CSPC Pharmaceutical Group Earnings and Revenue History

CSPC Pharmaceutical Group Debt to Assets

CSPC Pharmaceutical Group Cash Flow

CSPC Pharmaceutical Group Forecast EPS vs Actual EPS